CTRI/2025/04/085519尚未招募2 期
Comparative clinical study to evaluate the efficacy of Dashmool Sidha Taila Uttar Basti and Matra Basti in the management of Vat Ashthila wsr to Benign Prostate Hyperplasia (BPH)
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月7日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- 1) Improvement in sign and symptoms of Benign Prostate Hyperplasia
研究概览
简要总结
This is an open labelled parallel group study.
In this study, group A 30 patients will be administered with Dashmool Sidha Taila Uttar Basti for 7 days followed by a gap of 1 week for 28 days and group B 30 patients will be administered with Dashmool Sidha Taila Matra Basti for 7 days followed by a gap of 1 week for 28 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 40.00 Year(s) 至 75.00 Year(s)（—）
- 性别
- Male
入选标准
- •Patients suffering from sign and symptoms of Benign Prostate Hyperplasia 2) Residual urine should be less than 120 ml 2) Size of Prostate less than 40 cc.
排除标准
- •Patients suffering from Uncontrolled Diabetes Mellitus Tuberculosis Hepatitis Prostatitis and Malignancy 2) Residual urine greater than 120 ml 3) Size of Prostate greater than 40 cc 4) Catheterized patients.
结局指标
主要结局
1) Improvement in sign and symptoms of Benign Prostate Hyperplasia
时间窗: 28 days
3) Residual urine volume
时间窗: 28 days
2) Reduction in size of Prostate
时间窗: 28 days
次要结局
- 1) Improvement in sign and symptoms of Benign Prostate Hyperplasia(2) Recurrence of Benign Prostate Hyperplasia)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
The study between Nidhigdhikadi syrup and Brihati syrup in dry coughCTRI/2023/11/059747D chandrashekar60
尚未招募
不适用
A Clinical Study to compare the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the treatment of Artavakshaya in females of Polycystic Ovarian SyndromeCTRI/2025/04/084467Mamta Rani134
招募中
2 期
A study to compare rituximab standard dose versus low dose for lung disease in systemic sclerosis patientsCTRI/2025/05/087582Post Graduate Institute of Medical Education and Research, Chandigarh30
尚未招募
3 期
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNonalcoholic SteatohepatitisNCT05731596Tanta University46
Unknown
1 期
A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural MesotheliomaTo Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With ChemotherapyNCT02879669Targovax Oy31